🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
45 Servings
Botanical Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 120.0mg (440 products) 📚 187 studies (Tier A: 1, B: 71)
This product: 80mg
📊 Market median: 100.0mg (120 products)
Median 100.0mg This product: 60mg
📊 Market median: 100.0mg (284 products) 📚 10 studies (Tier A: 0, B: 4)
This product: 40mg

Other Ingredients

Hydroxypropyl Methylcellulose Microcrystalline Cellulose L-Leucine

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (80% of products) Nutrient (4% of products)

Target Groups

Adult (18 - 50 Years) No Allergies

Product Information

📋 Directions for Use

Suggested Use As a dietary supplement, 1 or 2 capsules two or three times daily with meals, or as directed by a healthcare practitioner.

🧪 Formulation Notes

A broad-spectrum formula containing three separate but complementary flavonoid classes: ginkgo flavone glycosides, bilberry anthocyanosides, and grape seed proanthocyanidins.

Our grape seed extract raw material comes from France, and contains not less then 95% total polyphenols, including 83% oligomeric proanthocyanidins.

Additional Information

Only standardized plant extracts are used.

Variations in product color may occur.

Keep in a cool, dry place, tightly capped.

Rev. 004

Product Details

UPC / SKU 7 13947 71490 8
DSLD Entry Date 2015-12-23
Product Type Botanical
Form Capsule
DSLD ID 54429
Data Updated 2026-04-11

Research Evidence

183 Research Sources
55 Avg Quality Score
86 Systematic Review
78 Meta Analysis
7 Other
4 Clinical Trial
2 Rct
2 Narrative Review
2 Regulatory Source
1 Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009
View all evidence for Ginkgo →

Compare Similar Products

View all Ginkgo products →